Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05137093 · ClinicalTrials.gov registry record
Scratching Validation Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 27
- Enrollment target
NCT05137093 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 27 participants.
The verdict
NCT05137093 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Single center, analyst-blinded, study comparing the scratching events identified via an actigraphy scoring algorithm versus manual scoring of an overnight video recording, undertaken in a sample of 40 adult patients with atopic dermatitis and controls.
Interventions
- DEVICE Actigraphy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-12-10 |
| Est. Completion | 2023-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05137093
The ClinicalTrials.gov registry entry for NCT05137093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Actigraphy Device is the first listed.
NCT05137093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05137093 about?
NCT05137093 is a clinical study titled "Scratching Validation Study". Single center, analyst-blinded, study comparing the scratching events identified via an actigraphy scoring algorithm versus manual scoring of an overnight video recording, undertaken in a sample of 40 adult patients with atopic dermatitis and controls.
What is the current status of trial NCT05137093?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-12-10. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT05137093?
The interventions under investigation include: Actigraphy Device (DEVICE).
Who is sponsoring clinical trial NCT05137093?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.